Patent ID: 6884807

Claim:
A 3-substituted quinuclidine compound represented by Formula I wherein - - - - represents an optional double bond; and R′ represents a bicyclic carbocyclic group which bicyclic carbocyclic group is optionally substituted one or more times with substituents selected from the group consisting of alkyl, alkoxy, alkoxyalkyl, cycloalkyl, cycloalkoxy, alkoxycycloalkyl, cycloalkoxyalkoxy, cycloalkylalkyl, hydroxyalkoxy, alkenyl, alkoxyalkenyl, alkynyl, alkoxyalkynyl, alkenoxy, alkynoxy, alkylthio, alkenylthio, alkynylthio, alkylseleno, alkenylseleno, alkynylseleno, methylenedioxy, trifluoromethanesulfonyloxy, halogen, —OH, —CF 3 , —OCF 3 , —CN, amino, nitro, oxime, alkyloxime, acyloxime, a group of the formula —(CO)R 3 , —COOR 3 , —O(CO)R 3 , —CONR 2 R 3 , —NH—CO 2 R 2 , —NHCO—R 2 and —OCO—NR 2 R 3 ; in which formulas R 2 and R 3 independently of each another represents hydrogen or alkyl; any of its enantiomers or any mixture of enantiomers, or a pharmaceutically acceptable salt thereof.